Volume | 769,005 |
|
|||||
News | - | ||||||
Day High | 200.21 | Low High |
|||||
Day Low | 198.06 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Laboratory Corporation of America Holdings | LH | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
200.00 | 198.06 | 200.21 | 199.45 | 199.97 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
18,404 | 769,005 | $ 198.93 | $ 152,981,733 | - | 195.01 - 243.30 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:31:20 | 1 | $ 199.45 | USD |
Laboratory Corporation o... (LH) Options Flow Summary
Laboratory Corporation of America Holdings Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.78B | 84.10M | - | 12.16B | 418M | 4.97 | 40.14 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Laboratory Corporation o... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 207.91 | 208.32 | 198.06 | 203.66 | 720,984 | -8.41 | -4.05% |
1 Month | 210.51 | 218.67 | 198.06 | 209.78 | 648,096 | -11.01 | -5.23% |
3 Months | 225.10 | 229.54 | 198.06 | 215.64 | 745,899 | -25.60 | -11.37% |
6 Months | 202.92 | 234.09 | 195.01 | 215.00 | 763,262 | -3.42 | -1.69% |
1 Year | 232.22 | 243.30 | 195.01 | 214.90 | 739,933 | -32.72 | -14.09% |
3 Years | 261.25 | 317.17 | 195.01 | 243.93 | 723,626 | -61.75 | -23.64% |
5 Years | 144.20 | 317.17 | 98.02 | 217.51 | 740,005 | 55.30 | 38.35% |
Laboratory Corporation o... Description
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. |